Home › Funds › Frazier Life Sciences Management, L.P. › SRPT

Frazier Life Sciences Management, L.P. position in SRPT

SAREPTA THERAPEUTICS INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 1,069,959 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$19.5M, representing 0.50% of its reported portfolio and ranking #31 among its reported holdings. Frazier Life Sciences Management, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)1.07M sh
Reported value held$19.49M
Portfolio Weight0.50%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s SRPT position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in SRPT in Q3 2026 at 1,069,959 shares (US$19.5M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 1.07M $19.49M New

About SRPT and 13F data

SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in SRPT — the largest reported positions include HIGHBRIDGE CAPITAL MANAGEMENT LLC (US$50.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRPT

All SRPT fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held SRPT?

Frazier Life Sciences Management, L.P. has disclosed SRPT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Frazier Life Sciences Management, L.P.'s current position in SRPT?

As of Q3 2026, Frazier Life Sciences Management, L.P. holds 1.07M shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $19.49M, representing 0.50% of its reported portfolio and ranking #31.

Has Frazier Life Sciences Management, L.P. been buying or selling SRPT?

In the latest 13F filing (Q3 2026), Frazier Life Sciences Management, L.P. newly opened its position in SRPT.

Which other funds hold SRPT?

Other major institutional holders of SRPT include HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 12 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.